CHRU de Besançon, France

Time frame: 1 December 2022 - 30 November 2023


The positions in the table below reflect the CHRU de Besançon's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the corresponding table where CHRU de Besançon is listed.

Position by research output Share

Global France
Overall 2873 116
Healthcare 706 22

Position by research output Share in subject areas

Global France
Biological sciences 2759 142
Chemistry 2363 123
Earth & environmental sciences 1606 99
Health sciences 1332 57


Overall research output

Count Share
Overall 35 1.10

Overall Count and Share for 'CHRU de Besançon' based on the 12-month time frame mentioned above.

View all articles

Research outputs by subject area

Subject Count Share
Biological sciences 13 0.13
Chemistry 1 0.08
Earth & environmental sciences 1 0.15
Health sciences 21 0.77

Note: Articles may be assigned to more than one subject area. Hover over the donut graph to view the Share for each subject.

Share output for the past 5 years

Compare with other institutions

Nature Strategy Reports

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.

  1. Actionable insights into research performance.

  2. Detailed analysis of strengths and weaknesses.

  3. Covers all major disciplines and regions of the world.

Nature Navigator

Data-driven insights for informed research strategy decisions with AI summarisation technology.

  1. Track trends, summarise articles effortlessly.

  2. Spark serendipitous discoveries.

  3. Uncover collaboration opportunities.


International vs domestic collaboration by Share

Type Percentage
International (430 institutions) 31.6%
Domestic (246 institutions) 68.4%

Note: Hover over the graph to view the percentage of collaboration.

Top 5 domestic collaborators with CHRU de Besançon by Share

Collaborating institutions


Top 5 international collaborators with CHRU de Besançon by Share

Collaborating institutions


  • Advertisement

Latest supplement

Nature Index 2024 Health Sciences

More money is being spent on medical R&D than ever before, but with few new drugs to show for it. The race is on to find technological solutions that will speed up drug development and deliver better clinical outcomes. Nature Index Health Sciences 2024 highlights the people and projects that are bringing fresh perspectives to some of the most complex challenges in medicine and provides an in-depth look at how one country – the United States – is dominating the field.

Nature Index 2024 Health Sciences